Home » Topics » Regulatory

Regulatory
RSS

FDA approves two pain products from Mallinckrodt

Sep. 6, 1996

Serostim FDA-approved for cachexia in AIDS patients

Aug. 30, 1996

Expanded H-BIG clinical development program announced

Aug. 30, 1996

FDA approves Helidac for marketing

Aug. 30, 1996

Botulinum toxin effective in treating writer's cramp

Aug. 30, 1996

Botulinum toxin effective in reducing upper limb spasticity

Aug. 30, 1996

Tegretol-XR launched in U.S.

Aug. 30, 1996

Famotidine tested in schizophrenic patients

Aug. 30, 1996

BMS, Sano to collaborate on transdermal BuSpar development

Aug. 30, 1996

Flunitrazepam may alter circadian sleep-wake rhythms

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Sept. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Sept. 18, 2025.
‘Prolific’ Regeneron won’t stop with phase III FOP data drop
BioWorld
“People have some inability to focus on [Regeneron Pharmaceuticals Inc.’s] pipeline,” which stands as “the most prolific in the industry, I would dare to say,”...
The ‘molecular revolution’ driving R&D of new cancer therapeutics
BioWorld Asia
“New explosions in biotechnology are allowing us to interrogate cancers at a very sophisticated level compared to before,” Dennis Slamon told audience members at...
Remynd’s REM-127 yields positive phase II data in Alzheimer’s
BioWorld
Remynd NV has turned in positive phase IIa data for a new target in Alzheimer’s disease, showing that restoring calcium homeostasis in neurons reduces levels of...